Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899]

BMC Gastroenterology

Volumn 3, Issue , 2003, Pages

  van Buuren, Henk R ^a   Rasch, Marijke C ^b   Batenburg, Piet L ^c   Bolwerk, Clemens J M ^d   Nicolai, Jan J ^e   van der Werf, Sjoerd D J ^f   Scherpenisse, Joost ^g   Arends, Lidia R ^a   van Hattum, Jan ^b   Rauws, Erik A J ^d   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Zuiderziekenhuis   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e LEYENBURG HOSPITAL   (Netherlands)

^f MEDICAL CENTER HAAGLANDEN   (Netherlands)

^g Reinier de Graaf Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DYSPHAGIA; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS DISEASE; ESOPHAGUS HEMORRHAGE; ESOPHAGUS OBSTRUCTION; ESOPHAGUS PERFORATION; ESOPHAGUS STENOSIS; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEALTH CARE COST; HEMATOMA; HIGH RISK PATIENT; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; MULTICENTER STUDY; PNEUMONIA; PRIMARY PREVENTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; RECURRENCE; SCLEROTHERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 2442701592     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-3-22     Document Type: Article

References (44)

1. Burroughs AK, D'Heygere F and McIntyre N: Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics. Hepatology 1986, 6:1407-1413.
2. Baker LA, Smith C and Lieberman G: The natural history of esophageal varices. A study of 115 cirhotic patietns in whom varies were diagnosed prior to bleeding. Am J Med 1959, 26:228-237.
3. Conn HO, Lindenmuth WW, May CJ and Ramsby GR: Prophylactic portacaval anastomosis. A tale of two studies. Medicine (Baltimore) 1972, 51:27-40.
4. Resnick RH, Chalmers TC, Ishihara AM, Garceau AJ, Callow AD, Schimmel EM and O'Hara ET: A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med 1969, 70:675-688.
5. Jackson FC, Perrin EB, Smith AG, Dagradi AE and Nadal HM: A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg 1968, 115:22-42.
6. Bernuau J and Rueff B: Treatment of acute variceal bleeding. Clin Gastroenterol 1985, 14:185-207.
7. Graham DY and Lacey Smith J: The course of patients after variceal haemorrhage. Gastroenterology 1981, 80:800-809.
8. Inokuchi K: Improved survival after prophylactic portal nondecompression surgery for esophageal varices: a randomized clinical trial. Hepatology 1990, 12:1-6.
9. Koch H, Henning H, Grimm H and Soehendra N: Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. Endoscopy 1986, 18:40-43.
10. Witzel L, Wolbergs E and Merki H: Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet 1985, 1:773-775.
11. Wordehoff D and Spech HJ: [Prophylactic sclerosing of esophageal varices. Results of a prospective randomized 7-year longitudinal study]. Dtsch Med Wochenschr 1987, 112:947-951.
12. Paquet KJ: Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy 1982, 14:4-5.
13. Terblanche J: Sclerotherapy for prophylaxis of variceal bleeding. Lancet 1986, 1:961-963.
14. Oberhammer E, Paquet KJ and Distelmayer W: Endoscopische Befunde bei portaler Hypertension unter Einschlusz der Nottfallenendoskopie. Therapiewoche 1978, 28:.
15. Zelen M: A new design for randomized clinical trials. New Eng J Med 1979, 300:1242-1245.
16. Taylor KM, Margolese RG and Soskolne CL: Physician's reasons for not entering eligible patients in a randomiozed controlled trial of surgery for breast cancer. N Engl J Med 1984, 310:1363-1367.
17. Pugh RNH, Murray-Lion IM, L. Dawson J. and et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
18. de Franchis R, Pascal JP, Ancona E, Burroughs A, Henderson JM, Fleig WE, Groszmann RJ, Bosch J, Sauerbruch T, Soederlund C, Lebrec D, Soerensen TIA and Pagliaro L: Definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 1992, 15:256-261.
19. Arends LR, Hoes AW, Lubsen J, Grobbee DE and Stijnen T: Baseline risk as predictor of treatment benefit: three clinical meta-reanalyses. Stat Med 2000, 19:3479-3518.
20. Paquet KJ, Kalk JF, Klein CP and Gad HA: Prophylactic sclerotherapy for esophageal varices in high-risk cirrhotic patients selected by endoscopic and hemodynamic criteria: a randomized, single-center controlled trial. Endoscopy 1994, 26:734-740.
21. Piai G, Cipolletta L, Claar M, Marone G, Bianco MA, Forte G, Iodice G, Mattera D, Minieri M, Rocco P and et al.: Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology 1988, 8:1495-1500.
22. De Franchis R, Primignani M, Arcidiacono PG, Rizzi PM, Vitagliano P, Vazzoler MC, Arcidiacono R, Rossi A, Zambelli A, Cosentino F and et al.: Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. Gastroenterology 1991, 101:1087-1093.
23. Kobe E, Zipprich B, Schentke KU and Nilius R: Prophylactic endoscopic sclerotherapy of esophageal varices--a prospective randomized trial. Endoscopy 1990, 22:245-248.
24. Paquet KJ: [Sclerotherapy for the prevention of bleeding esophageal varices]. Internist (Berl) 1983, 24:81-84.
25. D'Amico G: Prognostic stratification in analysis of RCT data. Portal hypertension III. Proceedings of the third Baveno international workshop on definitions, methodology and therapeutic strategies. Edited by: de Franchis R. Oxford, Blackwell Science Ltd; 2001:222-226.
26. Prediction of the first variceal haemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988, 319:983-989.
27. Merkel C, Zoli M, Siringo S, van Buuren HR, Magalotti D, Angeli P, Sacerdoti D, Bolondi L and Gatta A: Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000, 95:2916-2920.
28. Van Ruiswyk J and Byrd JC: Efficacy of prophylactic sclerotherapy for prevention of a first variceal hemorrhage. Gastroenterology 1992, 102:587-597.
29. D'Amico G, Pagliaro L and Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995, 22:332-354.
30. Pagliaro L, D'Amico G, Sorensen TI, Lebrec D, Burroughs AK, Morabito A, Tine F, Politi F and Traina M: Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992, 117:59-70.
31. Fardy JM and Laupacis A: A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994, 89:1938-1948.
32. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, de Franchis R, Wagner JL, Conn HO and Rodes J: Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998, 28:868-880.
33. de Franchis R: Developing consensus in portal hypertension. J Hepatol 1996, 25:390-394.
34. Potzi R, Bauer P, Reichel W, Kerstan E, Renner F and Gangl A: Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. Gut 1989, 30:873-879.
35. Sauerbruch T, Wotzka R, Kopcke W, Harlin M, Heldwein W, Bayerdorffer E, Sander R, Ansari H, Starz I and Paumgartner G: Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med 1988, 319:8-15.
36. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. The Copenhagen Esophageal Varices Sclerotherapy Project. N Engl J Med 1984, 311:1594-1600.
37. Santangelo WC, Dueno MI, Estes BL and Krejs GJ: Prophylactic sclerotherapy of large esophageal varices. N Engl J Med 1988, 318:814-818.
38. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. N Engl J Med 1991, 324:1779-1784.
39. Laine L and Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995, 123:280-287.
40. Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI and Chiang HT: Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol 1999, 31:451-456.
41. Sarin SK, Guptan RK, Jain AK and Sundaram KR: A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol 1996, 8:337-342.
42. Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, Wu KL and Lo KJ: Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997, 25:1346-1350.
43. Sarin DS, Lamba GS, Kumar M, Misra A and Murthy NS: Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999, 340:988-993.
44. de Franchis R: Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000, 33:846-852.